COMMUNIQUÉS West-GlobeNewswire

Scilex Holding Company Announces Closing of Exercise of Warrants for $20.3 Million Gross Proceeds
25/11/2025
PALO ALTO, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non- [...]
Este Surgery Announces Advanced DHI Hair Transplant Technology in Turkey's Medical Tourism Sector
25/11/2025
Turkey Raises the Bar in Medical Tourism with Advanced DHI Hair Transplant Technology Istanbul, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Turkey's growing share of the global medical tourism market has led to significant [...]
Brown’s Medical Imaging and Prestige Medical Imaging Merge, Expanding Nationwide Service Capabilities
25/11/2025
Combined platform strengthens national footprint, enhances multi-vendor service expertise, and accelerates customer-first innovation OMAHA, Neb., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Brown’s Medical Imaging (“Brown’s” or [...]
Akari Therapeutics Announces Release of the Next CEO Corner Segment
25/11/2025
Access the Akari CEO Corner here BOSTON and LONDON, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payloads for antibody drug conjugates ( [...]
INVO Fertility Announces a 1:8 Reverse Stock Split Effective Pre-Market Opening on November 28, 2025
25/11/2025
SARASOTA, Fla., Nov. 25, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (“INVO”) (NASDAQ: IVF), a healthcare company focused on the fertility market, announced today that it will effect a 1-for-8 reverse split of its [...]
Erasca to Present at the 8th Annual Evercore Healthcare Conference
25/11/2025
SAN DIEGO, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/ [...]
Silexion Therapeutics Successfully Completes Toxicology Studies for SIL204, Next-Generation RNA Silencing Therapy, Ahead of Phase 2/3 Clinical Trial in Pancreatic Cancer
25/11/2025
Successful completion of two-species toxicology studies confirms no systemic organ toxicity, advancing the Company towards its planned regulatory submissions to Israel and Germany Company remains on track to initiate [...]
Lancement du Prix AbbVie des innovateurs en biotechnologies au Québec : AbbVie et adMare BioInnovations encouragent l’innovation dans le domaine des sciences de la vie
25/11/2025
Le lancement d’un concours national, en collaboration avec adMare BioInnovations, illustre l’engagement d’AbbVie à favoriser le dynamisme de l’écosystème des biotechnologies au Québec. L’entreprise biotechnologique [...]
AbbVie and adMare BioInnovations Foster Life Sciences Innovation with the Launch of the AbbVie Biotech Innovators Award in Quebec
25/11/2025
National competition, in collaboration with adMare BioInnovations, demonstrates AbbVie's commitment to a thriving biotech ecosystem in Quebec One biotech will receive a year of laboratory and office space including [...]
San Diego’s Premier Neurological-Spine Care Clinic Launches Massive Holiday NUCCA Promotion: 50% Off for New Patients Through Dec. 31
25/11/2025
SAN DIEGO, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Just in time for the year-end wellness rush, Origin Modern Health & Wellness is offering 50 % off its signature evaluation and care plan for new patients through December [...]
LifeLabs Donates $10,000 to Women in Crisis in Honour of the International Day for the Elimination of Violence Against Women and Girls.
25/11/2025
Proud to Support a Foundation for a World Free of Gender-Based Violence Toronto, Ontario, Nov. 25, 2025 (GLOBE NEWSWIRE) -- LifeLabs, Canada's leading provider of medical diagnostic services, is proud to donate $10,000 [...]
Branded Legacy Announces Strong Revenues from Newly Acquired Pau Hana Subsidiary
25/11/2025
Pau Hana Plans Ambitious Expansion Roadmap and New Location Acquisitions in the Pipeline MELBOURNE, Fla., Nov. 25, 2025 (GLOBE NEWSWIRE) -- via IBN -- Branded Legacy, Inc. (OTC:BLEG), a leader in innovative addiction [...]
Health Care Resource Centers Appoints Dr. Katherine Krauskopf as Regional Medical Director in Western Massachusetts
25/11/2025
To lead addiction treatment programs across Greenfield, Westfield, Northampton, and Chicopee CHICOPEE, Mass., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Health Care Resource Centers (HCRC), a BayMark Health Services company, has [...]
C4 Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference
25/11/2025
WATERTOWN, Mass., Nov. 25, 2025 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced [...]
Kymera Therapeutics Announces First Patient Dosed in BROADEN2 Phase 2b Atopic Dermatitis Clinical Trial of KT-621, a First-in-Class, Oral STAT6 Degrader
25/11/2025
Data from the KT-621 BROADEN2 Phase 2b AD patient trial expected to be reported by mid-2027 KT-621 BREADTH Phase 2b trial in asthma on track to initiate in 1Q26 Completed dosing in KT-621 BroADen Phase 1b AD trial with [...]
Invivyd to Participate at the 8th Annual Evercore Healthcare Conference
25/11/2025
NEW HAVEN, Conn., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that management will participate in a fireside chat at the 8 th Annual Evercore Healthcare Conference on Tuesday, December [...]
Kraig Biocraft Laboratories Launches Significant Hiring Initiative to Support Expanded Spider Silk Production Footprint in Southeast Asia
25/11/2025
ANN ARBOR, Mich., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, announces the launch of a key hiring initiative [...]
Clearmind Medicine Kicks-Off Patient Enrollment at Tel Aviv Sourasky Medical Center, Adding Another Site Activated in its in Phase I/IIa Alcohol Use Disorder Trial
25/11/2025
First patient recruited at leading Israeli site accelerating enrollment momentum across global study of CMND-100 Vancouver, Canada, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0 [...]
Anavex Life Sciences Reports Fiscal 2025 Fourth Quarter Financial Results and Provides Business Update
25/11/2025
Company to host a webcast t oday at 8:30 a.m. Eastern Time NEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company [...]

Pages